Sign In
Buy GTLL
$0.0002
+0 (+0%)
At Close: Jun 03, 2026
Digital Turbine to Participate in The Bank of America Global Technology Conference
01:01pm, Thursday, 28'th May 2026
Austin, Texas, May 28, 2026 /PRNewswire/ -- Digital Turbine, Inc. (Nasdaq: APPS) announced today that it will be participating in the Bank of America Global Technology Conference in San Francisco, CA
Simon® is Teaming up with adidas® to Offer Fan Experiences for a Summer of Global Soccer
12:56pm, Thursday, 28'th May 2026
Immersive fan experiences, exclusive retail, and high - energy events bring soccer excitement to Simon destinations nationwide INDIANAPOLIS, May 28, 2026 /PRNewswire/ -- Simon ®, a real estate invest
WEST PALM BEACH, FL / ACCESS Newswire / May 28, 2026 / As global financial markets continue surging with renewed investor enthusiasm, Elektros Inc. is pleased to announce increasing worldwide awarenes
WEST PALM BEACH, FL / ACCESS Newswire / May 28, 2026 / Elektros Inc. (OTC Pink:ELEK) As U.S. equity markets continue rallying near historic highs, Elektros Inc. is pleased to announce growing worldwid
Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders?
09:15am, Thursday, 28'th May 2026
As the market finds itself in the thick of Q2 earnings season, there is—per usual—a considerable amount of noise. Companies that have handily beaten consensus expectations have been punished, whil
RenX's Myakka Biomass Platform Targets Domestic Share of Soil Amendments Market with Planned Substrate Production
09:10am, Thursday, 28'th May 2026
Global soil amendments market valued at approximately $19.6 billion in 2025, projected to grow at an 11.2% CAGR through 2030 Global soil amendments market valued at approximately $19.6 billion in 2025
MELBOURNE, Australia & AUCKLAND, New Zealand, May 28, 2026 (GLOBE NEWSWIRE) -- Braiin Limited (NASDAQ: BRAI) today announced its official launch into the New Zealand market with the rollout of its AI-
Vor Bio to Participate in the 2026 Jefferies Global Healthcare Conference
08:30am, Thursday, 28'th May 2026
BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will provide a corpora
Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
08:30am, Thursday, 28'th May 2026
THE WOODLANDS, Texas, May 28, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 2026 Jefferies G
Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
08:30am, Thursday, 28'th May 2026
WAYNE, Pa., May 28, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammator
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
08:05am, Thursday, 28'th May 2026
WEST CHESTER, Pa., May 28, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of
Varex to Present at the Jefferies Global Healthcare Conference
08:00am, Thursday, 28'th May 2026
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the Jefferies Global Healthcare Conference in New York. Management
Monster Beverage Announces Participation in dbAccess Global Consumer Conference 2026
08:00am, Thursday, 28'th May 2026
CORONA, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Monster Beverage Corporation (NASDAQ: MNST) announced today that members of its senior management team will participate in a fireside chat at the dbAcc
Eupraxia Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
08:00am, Thursday, 28'th May 2026
VANCOUVER, British Columbia, May 28, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging it
Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference
08:00am, Thursday, 28'th May 2026
EMERYVILLE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to
